International Stem Cell CORP (ISCO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, International Stem Cell CORP reported revenue of $9.10M, up 0.2% from the prior year. The company ran a net loss, with a net margin of -4.6%. It held $4.82M in total assets against $4.58M in total liabilities.
Key ratios (FY2025)
-2.9%
Operating margin
-4.6%
Net margin
+0.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.10M | $9.09M | $7.79M | $8.18M | $7.18M | $7.13M | $9.47M | $11.09M | $7.46M | — |
| Cost of Revenue | $4.03M | $3.76M | $3.18M | $3.27M | $2.94M | $2.78M | $3.93M | $4.07M | $2.12M | $1.94M |
| Operating Income | -$267.0K | -$68.0K | -$663.0K | -$183.0K | -$1.92M | -$2.82M | -$5.73M | -$3.47M | -$4.94M | -$4.85M |
| Net Income | -$418.0K | -$209.0K | -$131.0K | -$331.0K | -$899.0K | -$2.72M | -$4.26M | -$2.13M | -$6.07M | -$1.08M |
| EPS (Diluted) | $-0.05 | $-0.03 | $-0.02 | $-0.04 | $-0.11 | — | — | $-0.33 | $-1.46 | $-0.34 |
| Total Assets | $4.82M | $5.17M | $5.39M | $5.13M | $4.95M | $5.29M | $6.62M | $7.80M | $6.86M | $7.04M |
| Total Liabilities | $4.58M | $4.80M | $5.28M | $5.36M | $5.23M | $5.32M | $5.21M | $5.26M | $4.80M | — |
| Shareholders' Equity | -$4.06M | -$3.93M | -$4.19M | -$4.52M | -$4.59M | -$4.33M | -$2.89M | $2.54M | $2.06M | $3.44M |
| Cash & Equivalents | — | — | — | — | — | — | — | — | $304.0K | $110.0K |
| Operating Cash Flow | $8.0K | $13.0K | $929.0K | $332.0K | -$1.30M | -$341.0K | -$1.40M | -$1.08M | -$2.14M | — |
| Capital Expenditures | $43.0K | $166.0K | $80.0K | $1.0K | $23.0K | $28.0K | $164.0K | $185.0K | $112.0K | $231.0K |
| Shares Outstanding | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M | 7.54M | 7.54M | 6.93M | 6.06M | 3.95M |